Cotzias GC, Van Woert MH, Schiffer LM. Aromatic amino acids and modification of parkinsonism. N Engl J Med. 1967;276(7):374–9.
CAS
Article
PubMed
Google Scholar
Mena I, Cotzias GC. Protein intake and treatment of Parkinson’s disease with levodopa. N Engl J Med. 1975;292(4):181–4.
CAS
Article
PubMed
Google Scholar
Carter JH, Nutt JG, Woodward WR, Hatcher LF, Trotman TL. Amount and distribution of dietary protein affects clinical response to levodopa in Parkinson’s disease. Neurology. 1989;39(4):552–6.
CAS
Article
PubMed
Google Scholar
Tsui JK, Ross S, Poulin K, Douglas J, Postnikoff D, Calne S, Woodward W, Calne DB. The effect of dietary protein on the efficacy of L-dopa: a double-blind study. Neurology. 1989;39(4):549–52.
CAS
Article
PubMed
Google Scholar
Pincus JH, Barry K. Influence of dietary protein on motor fluctuations in Parkinson’s disease. Arch Neurol. 1987;44(3):270–2.
CAS
Article
PubMed
Google Scholar
Eriksson T, Granerus AK, Linde A. Carlsson A: ‘On-off’ phenomenon in Parkinson’s disease: relationship between dopa and other large neutral amino acids in plasma. Neurology. 1988;38(8):1245–8.
CAS
Article
PubMed
Google Scholar
Pincus JH, Barry KM. Plasma levels of amino acids correlate with motor fluctuations in parkinsonism. Arch Neurol. 1987;44(10):1006–9.
CAS
Article
PubMed
Google Scholar
Croxson S, Johnson B, Millac P, Pye I. Dietary modification of Parkinson’s disease. Eur J Clin Nutr. 1991;45(5):263–6.
CAS
PubMed
Google Scholar
Nutt JG, Woodward WR, Carter JH, Trotman TL. Influence of fluctuations of plasma large neutral amino acids with normal diets on the clinical response to levodopa. J Neurol Neurosurg Psychiatry. 1989;52(4):481–7.
CAS
Article
PubMed
PubMed Central
Google Scholar
Barichella M, Marczewska A, De Notaris R, Vairo A, Baldo C, Mauri A, Savardi C, Pezzoli G. Special low-protein foods ameliorate postprandial off in patients with advanced Parkinson’s disease. Mov Disord. 2006;21(10):1682–7.
Article
PubMed
Google Scholar
Bracco F, Malesani R, Saladini M, Battistin L. Protein redistribution diet and antiparkinsonian response to levodopa. Eur Neurol. 1991;31(2):68–71.
CAS
Article
PubMed
Google Scholar
Gimenez-Roldan S, Mateo D, Garcia Almansa A, Garcia Peris P. Proposal for a protein redistribution diet in the control of motor fluctuations in Parkinson’s disease: acceptance and efficacy. Neurologia. 1991;6(1):3–9.
CAS
PubMed
Google Scholar
Karstaedt PJ, Pincus JH. Protein redistribution diet remains effective in patients with fluctuating parkinsonism. Arch Neurol. 1992;49(2):149–51.
CAS
Article
PubMed
Google Scholar
Pare S, Barr SI, Ross SE. Effect of daytime protein restriction on nutrient intakes of free-living Parkinson’s disease patients. Am J Clin Nutr. 1992;55(3):701–7.
CAS
PubMed
Google Scholar
Pincus JH, Barry K. Protein redistribution diet restores motor function in patients with dopa-resistant “off” periods. Neurology. 1988;38(3):481–3.
CAS
Article
PubMed
Google Scholar
Riley D, Lang AE. Practical application of a low-protein diet for Parkinson’s disease. Neurology. 1988;38(7):1026–31.
CAS
Article
PubMed
Google Scholar
Leenders KL, Poewe WH, Palmer AJ, Brenton DP, Frackowiak RS. Inhibition of L-[18 F] fluorodopa uptake into human brain by amino acids demonstrated by positron emission tomography. Ann Neurol. 1986;20(2):258–62.
CAS
Article
PubMed
Google Scholar
Daniel PM, Moorhouse RS, Pratt OE. Letter: Do changes in blood levels of other aromatic aminoacids influence levodopa therapy? Lancet. 1976;1(7950):95.
CAS
Article
PubMed
Google Scholar
Oldendorf WH. Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection. Am J Physiol. 1971;221(6):1629–39.
CAS
PubMed
Google Scholar
Wade LA, Katzman R. Synthetic amino acids and the nature of L-DOPA transport at the blood–brain barrier. J Neurochem. 1975;25(6):837–42.
CAS
Article
PubMed
Google Scholar
Nutt JG, Fellman JH. Pharmacokinetics of levodopa. Clin Neuropharmacol. 1984;7(1):35–49.
CAS
Article
PubMed
Google Scholar
Simon N, Gantcheva R, Bruguerolle B, Viallet F. The effects of a normal protein diet on levodopa plasma kinetics in advanced Parkinson’s disease. Parkinsonism Relat Disord. 2004;10(3):137–42.
Article
PubMed
Google Scholar
Cereda E, Barichella M, Pedrolli C, Pezzoli G. Low-protein and protein-redistribution diets for Parkinson’s disease patients with motor fluctuations: a systematic review. Mov Disord. 2010;25(13):2021–34.
Article
PubMed
Google Scholar
Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55(3):181–4.
CAS
Article
PubMed
PubMed Central
Google Scholar
Hauser RA. Levodopa/carbidopa/entacapone (Stalevo). Neurology. 2004;62(1 Suppl 1):S64–71.
CAS
Article
PubMed
Google Scholar
Koller WC, Hutton JT, Tolosa E, Capilldeo R. Immediate-release and controlled-release carbidopa/levodopa in PD: a 5-year randomized multicenter study. Carbidopa/Levodopa Study Group Neurol. 1999;53(5):1012–9.
CAS
Google Scholar
Marder K, Levy G, Louis ED, Mejia-Santana H, Cote L, Andrews H, Harris J, Waters C, Ford B, Frucht S et al. Familial aggregation of early- and late-onset Parkinson’s disease. Ann Neurol. 2003;54(4):507–13.
Article
PubMed
Google Scholar
Payami H, Zareparsi S, James D, Nutt J. Familial aggregation of Parkinson disease: a comparative study of early-onset and late-onset disease. Arch Neurol. 2002;59(5):848–50.
Article
PubMed
Google Scholar
Tanner CM, Ottman R, Goldman SM, Ellenberg J, Chan P, Mayeux R, Langston JW. Parkinson disease in twins: an etiologic study. JAMA. 1999;281(4):341–6.
CAS
Article
PubMed
Google Scholar
Barichella M, Cereda E, Pezzoli G. Major nutritional issues in the management of Parkinson’s disease. Mov Disord. 2009;24(13):1881–92.
Article
PubMed
Google Scholar